OTCFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for FMCB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Continue quarterly cash dividends | The company regularly pays quarterly cash dividends. | Intact | Dividend payments are cut or suspended | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional banking business with a measured growth profile, not a speculative growth story. The 1-to-3-year thesis is intact, though the risk label has recently risen from moderate to elevated.
Valuation is described as cheap, even though FMCB trades at a premium to peers. Expectations appear broadly aligned with the evidence, with a small negative expectations gap, and the priced-in assessment is tagged justified with low fragility.
Near term, management’s relationship-led growth effort is delivering: loans and leases rose 3.77% year over year, while deposits rose 1.74%, slower than the prior quarter’s reported pace. Capital strengthened, but cash declined from the prior quarter and net charge-offs increased year over year, leaving credit quality and liquidity as watch points.
A guidance cut at the next call would be a meaningful negative, and rate cuts from the current 3.88% level could weigh on financial-sector conditions. On the favorable side, continued earnings strength and higher guidance from sector bellwethers could support sector momentum; FMCB’s own credit quality and deposit growth also remain important to track.
For the next 1 to 3 years, the thesis rests on continued client-led growth and capital strength without a material deterioration in credit quality or guidance. Recent performance leaves the thesis intact, but the elevated risk label calls for attention to those execution points. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Farmers & Merchants Bancorp plans to earn about $134 per share in 2026. |
| Intact |
| EPS falls below $133.96 in 2026 |
Diluted EPS: $36.39 per share FY2026-Q2; GAAP. Published target: >=133.96 USD_PER_SHARE. Target period ends 2026-12-31; this observation covers 2026-Q2. Aug 6, 202636.39 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain $1.8 billion in cash and investments | It keeps a strong cash and investment position near $1.8 billion. | Intact | Cash and investments fall below $1.8 billion | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.